Full Text
PCN88 HOW ARE WE ASSESSING THE VALUE FOR MONEY OF CANCER BIOMARKERS IN ECONOMIC EVALUATIONS?

Abstract

Authors

M.K. Seo

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×